Bartram Richard 4
4 · Esperion Therapeutics, Inc. · Filed Jan 3, 2018
Insider Transaction Report
Form 4
Bartram Richard
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2018-01-02+38,500→ 38,500 totalExercise: $66.50Exp: 2028-01-02→ Common Stock (38,500 underlying) - Exercise/Conversion
Common Stock
2018-01-02$3.70/sh+17,892$66,200→ 19,092 total - Exercise/Conversion
Stock Option (right to buy)
2018-01-02+17,892→ 0 totalExercise: $3.70Exp: 2018-04-24→ Common Stock (17,892 underlying)
Footnotes (2)
- [F1]The options vest over a four (4) year period in equal quarterly installments, the first of which will be on April 2, 2018.
- [F2]The options are fully vested as of the date hereof.